

How New Clinical Trials Are Revolutionizing ER Positive Breast Cancer Treatment
Recent innovations in breast cancer clinical trials are ushering in a transformative era for estrogen receptor-positive (ER+) breast cancer treatment. Groundbreaking therapies like the use of estrogen with PARP inhibitors, the introduction of elacestrant as an oral SERD, and the life-changing triplet therapies are changing the game. Many advancements are expanding treatment options, significantly enhancing […]
3 min read